ClearPoint Neuro Inc CLPT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CLPT is a good fit for your portfolio.
News
-
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
-
ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024
-
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
-
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT)
-
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
-
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
-
Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System
-
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
Trading Information
- Previous Close Price
- $5.32
- Day Range
- $5.19–5.40
- 52-Week Range
- $4.05–10.80
- Bid/Ask
- $5.05 / $5.60
- Market Cap
- $143.74 Mil
- Volume/Avg
- 151,452 / 158,215
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.46
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 107
- Website
- https://www.clearpointneuro.com
Comparables
Valuation
|
Metric
|
CLPT
|
SIBN
|
NVRO
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 6.19 | 3.66 | 1.55 |
Price/Sales | 5.46 | 4.22 | 1.06 |
Price/Cash Flow | — | — | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CLPT
|
SIBN
|
NVRO
|
|---|---|---|---|
Quick Ratio | 3.55 | 8.01 | 4.82 |
Current Ratio | 4.87 | 9.01 | 6.37 |
Interest Coverage | — | −13.52 | −12.98 |
Quick Ratio
CLPT
SIBN
NVRO
Profitability
|
Metric
|
CLPT
|
SIBN
|
NVRO
|
|---|---|---|---|
Return on Assets (Normalized) | −33.37% | −8.97% | −5.64% |
Return on Equity (Normalized) | −56.32% | −12.61% | −11.08% |
Return on Invested Capital (Normalized) | −39.37% | −11.78% | −7.81% |
Return on Assets
CLPT
SIBN
NVRO
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Pkhszjf | Nfpmlpz | $185.5 Bil | |
SYK
| Stryker Corp | Nrcgxyjy | Svtr | $128.2 Bil | |
MDT
| Medtronic PLC | Hxcklrry | Mkhgkt | $106.7 Bil | |
BSX
| Boston Scientific Corp | Cjszfxy | Hsfqqfg | $99.0 Bil | |
DXCM
| DexCom Inc | Ggmbxwddb | Fbxxx | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Gswbhmbxc | Mzjjy | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Glyqnppth | Mtwr | $24.9 Bil | |
ALGN
| Align Technology Inc | Dlwtwjtg | Spskw | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Llwxpktr | Vbbqvr | $18.9 Bil | |
PODD
| Insulet Corp | Qthcwnlny | Hpglfb | $11.7 Bil |